SEC Filing Analysis: Concentra Group Holdings Parent, Inc. (CON)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director received a routine, non-cash grant of restricted stock as part of their compensation.
• Market Impact: Neutral. The transaction is too small to have a material impact on the stock.

Company Information

Field	Value
Company	Concentra Group Holdings Parent, Inc.
Ticker Symbol	CON
CIK	0002014596
Industry	Specialty Outpatient Facilities

Insider Information

Field	Value
Name	Thomas Daniel
CIK	0001784668
Title/Position	Director
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-04
Transaction Code	A (Grant)
Security Type	Common Stock
Shares Involved	7,748
Price Per Share	$0.00
Total Value	$0
Shares Owned After	74,000
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.0%
Shares Transacted	7,748
% of Shares Outstanding	0.006%
Post-Transaction Ownership	74,000 shares (0.058% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value is $0, making it immaterial against the company's $2.45 billion market capitalization.
• Dilution Impact: The grant of 7,748 shares represents a negligible 0.006% dilution to the 128.17 million shares outstanding. This is a routine level of dilution for executive compensation and has no meaningful impact on existing shareholders.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a standard, non-cash award of restricted stock to a director. Such grants are common forms of compensation and do not signal new information to the market.

Volume & Sentiment

• Expected Volume Impact: None. As a non-market transaction, this filing will not directly influence trading volume.
• Sentiment Indicator: Neutral. The market generally views routine stock grants as a standard cost of business.

Additional Context

Transaction Notes

• Special Circumstances: The filing's footnote indicates this is a grant of restricted stock that will vest in full on the first anniversary of the grant date, November 4, 2026.